Delivery Order SPE2DB22D3011-SPE2DB25FQ0TH

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,870.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Protopam Chloride 1 GM vials, a medical product, with a period of performance through January 6, 2025. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $1,517.25, is for the delivery of PROTOPAM CHLORIDE 1 GM VIALS to support military treatment programs and facilities. It is a firm fixed price delivery order contract with a period of performance through March...
This federal contract award, valued at $807,318.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price with an ultimate completion date of January 16, 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
This federal contract award, valued at $1,513.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of April 18, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,260.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of May 8, 2025, is not set aside and allows for the supply of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award, valued at $1,377.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $844,462.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is April 25, 2024. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes...
This federal contract award, valued at $25,534.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, and an ultimate completion date of May 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,125.12, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of March 10, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award, valued at $261,525.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ0TH
    Delivery Order

This federal contract award, valued at $1,451.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D3011|SPE2DB25FQ0TH) for the supply of 4,568,168,571 units of Protopam Chloride 1 GM vials, with a performance period ending on May 8, 2025. This contract is not set-aside and was awarded on May 7, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 (SPE2DX), which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/6/25, 9:51 AM